Revenio Group Corporation Stock Exchange Release August 5, 2013 at 12.05 a.m. INVITATION TO REVENIO'S CAPITAL MARKETS DAY ON AUGUST 28, 2013 We invite analysts, portfolio managers and media representatives to attend Revenio Group Corporation's Capital Markets Day, which will be held in Pörssitalo at Fabianinkatu 14, 00100 Helsinki, on Wednesday August 28, 2013 starting at 11:30 a.m. At the event, we will present Revenio's updated strategy, growth drivers, Icare's business model and customer comments on our products, and provide an overview of our US markets. During the day, you will see presentations by Olli- Pekka Salovaara, President and CEO of Revenio; Timo Hildén, CEO of Icare Finland Oy, and John Floyd, CEO of Icare USA. You will also have the opportunity to hear interviews with some of the world's leading glaucoma researchers and doctors. The event will end at approximately 4:00 p.m. Registration will begin at 11:30 a.m. A buffet lunch will be served before the presentations begin. Presentations are scheduled to start at 12:00 noon. To register, please send e-mail to Ms. Laura Salovaara: laura.salovaara@revenio.fi or call +358 40 7516718 by August 20. Please note that the number of attendants is limited. Revenio Group Corporation For additional information: Pekka Raatikainen, CFO Tel. +358 50 553 4094 E-mail pekka.raatikainen@revenio.fi DISTRIBUTION: NASDAQ OMX Helsinki Financial Supervisory Authority (FIN-FSA) Principal media www.revenio.fi The Revenio Group in brief Revenio is a Finnish health tech group whose core business is tonometers. The Revenio Health Tech segment comprises the business operations of Icare Finland Oy. The widely patented Icare product family is the current cornerstone of the Group's success. Revenio seeks vigorous growth in health technology, both organically and through acquisitions and mergers. The Revenio Group also includes other business operations, which are grouped under the Technology and Services segment. This segment's operations have a shared global market and represent the cutting edge of technology products and services in their industry. These businesses are extremely profitable in their industries and generate positive cash flow. In 2012, the Revenio Group's net sales totaled EUR 25.4 million, with its operating margin standing at 19.4 percent. The Revenio Group Corporation is listed on NASDAQ OMX Helsinki. [HUG#1721074]
Revenio Group Corporation: INVITATION TO REVENIO'S CAPITAL MARKETS DAY ON AUGUST 28, 2013
| Source: Revenio Group Oyj